TRIM21 and cancer: Together, our data demonstrate that CSN6-facilitated self-ubiquitination and subsequent degradation of TRIM21 alters cancer stemness and that overexpression of CSN6 in cancer leads to deregulation of the TRIM21–OCT1–ALDH1A1 axis, thereby promoting cancer stemness during tumorigenesis (Fig. S2).